-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
-
Summary
-
Phathom Pharmaceuticals, Inc. quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from Q1 2018 to Q2 2024.
- Phathom Pharmaceuticals, Inc. Net Income (Loss) Attributable to Parent for the quarter ending June 30, 2024 was -$91.4M, a 123% decline year-over-year.
- Phathom Pharmaceuticals, Inc. Net Income (Loss) Attributable to Parent for the twelve months ending June 30, 2024 was -$297M, a 60.7% decline year-over-year.
- Phathom Pharmaceuticals, Inc. annual Net Income (Loss) Attributable to Parent for 2023 was -$202M, a 1.96% decline from 2022.
- Phathom Pharmaceuticals, Inc. annual Net Income (Loss) Attributable to Parent for 2022 was -$198M, a 37.4% decline from 2021.
- Phathom Pharmaceuticals, Inc. annual Net Income (Loss) Attributable to Parent for 2021 was -$144M, a 11.5% decline from 2020.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Quarterly (USD)
Net Income (Loss) Attributable to Parent, YoY Quarterly Growth (%)